Navigation Links
Crohn's & Colitis Foundation Issues Annual Report
Date:9/10/2009

Voices of Progress Highlights Accomplishments During Financially Challenging Environment

New York, New York (PRWEB) September 10, 2009 -- The Crohn's & Colitis Foundation of America, the leading nonprofit aimed at finding a cure for the 1.4 million Americans living with Crohn's disease and ulcerative colitis, chronic and painful digestive diseases, today announced that its 2008 Annual Report, Voices of Progress is available at http://www.ccfa.org/about/annual_report.

The 2008 fiscal year was a watershed year for the Foundation as it reached new fundraising and research milestones. Over $15.5 million was invested in research this year, roughly two and a half times what the Foundation allocated only a couple of years ago. This allowed the Foundation to fund 53 research projects, an excellent accomplishment in what continues to be a financially challenging environment. The report shows how donated funds are being well spent in support of the organization's research and other key initiatives.

"This year's annual report serves well as a reminder of what a committed organization can accomplish," says Richard J. Geswell, President of the Crohn's & Colitis Foundation of America. "Not only has the Crohn's & Colitis Foundation doubled its research investment in only a few years, but expanded its advocacy and patient and professional programs on a local and national level, reaching new heights, delivering up-to-date, critical information and support to the Crohn's and colitis community."

In the world of basic and clinical research, Crohn's & Colitis Foundation investments became highly visible during this fiscal year. The report prominently features the progress by top scientists and physicians in the Foundation's Human Gut Microbiome Initiative and its Pediatric Network's Risk Stratification in Crohn's Initiative. The report also discusses the Pregnancy Registry of the Clinical Alliance, which has made impressive headway in gaining timely information about pregnancy and post-natal outcomes in women with Crohn's and colitis. The report explains that crucial work like this provides short-term improvements in patient care and a foundation for applying scientific discoveries to patient-based research.

In addition, the Foundation's many patient and professional education, patient support programs, advocacy, and key fundraising initiatives are reviewed in the report, revealing many milestones accomplished during the 2008 fiscal year.

About Crohn's Disease and Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 80 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance and the American Institute of Philanthropy. For more information, contact the Foundation at 800-932-2423 or visit the CCFA web site.

MEDIA CONTACT:
Ariella Levine
Crohn's & Colitis Foundation
646-943-7430

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2857824.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Source of Information on Crohn's Disease and Ulcerative Colitis Medications
2. Get Your Fruits & Veggies: CDC
3. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
4. Story ideas from molecular & cellular proteomics
5. Job picture for 2006 chemistry grads reasonably good, C&EN reports
6. Debut issue of Foot & Ankle Specialist
7. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
8. IU Health & Wellness: Research and insights from Indiana University
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. European Society of Human Reproduction & Embryology 24th annual meeting
11. IU Health & Wellness: New research findings from the Kinsey Institute
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Crohn's & Colitis Foundation Issues Annual Report 
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... planning services and products in the developing world, is pleased to release their ... prevent over 5 million unwanted pregnancies, almost 14,000 maternal deaths and 3.8 million ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Clearinghouse supporting the real time adjudication of medical service claims by Pharmacy Benefit ... their current medical claims management software. The TransactRx Cross Benefit Clearinghouse receives standard ...
(Date:5/25/2016)... ... , ... The University of San Francisco (USF) has named Margaret Wooding Baker ... of more than 100 full-time faculty and staff, and serve as a member of ... , Baker comes to USF from the University of Washington in Seattle, where she ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & Wellness Center ... hands of time of female aging. The Juliet™ procedure helps to ... such as leakage, laxity, itchiness and pain have reported real relief from these and ...
(Date:5/25/2016)... ... May 25, 2016 , ... Researchers from SUNY State ... Meeting for their work on visual evoked potential and human attention. The article, ... used the Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, Inc., ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology: